Basit öğe kaydını göster

dc.contributor.authorAsa, S.
dc.contributor.authorSonmezoglu, K.
dc.contributor.authorHalac, M.
dc.contributor.authorTan, Y. Z.
dc.contributor.authorOzhan, M.
dc.contributor.authorYilmaz, S.
dc.date.accessioned2021-03-06T21:13:55Z
dc.date.available2021-03-06T21:13:55Z
dc.date.issued2012
dc.identifier.citationYilmaz S., Tan Y. Z. , Ozhan M., Halac M., Asa S., Sonmezoglu K., "FDG PET/CT in monitoring treatment of retroperitoneal fibrosis", REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.31, ss.338-339, 2012
dc.identifier.issn2253-654X
dc.identifier.otherav_fdc2d2e5-abc1-4450-be69-068f2970c6bd
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/165996
dc.identifier.urihttps://doi.org/10.1016/j.remn.2012.04.001
dc.description.abstractRetroperitoneal fibrosis is an uncommon disease characterized by inflammatory fibrosis typically surrounding abdominal aorta and iliac arteries. The glucose analogue F18-fluorodeoxyglucose can be used to image inflammatory cell activity non-invasively by PET. In this report we investigated the usefulness of the FDG PET/CT in the disease activity and therapy response evaluation of retroperitoneal fibrosis. (C) 2012 Elsevier Espana, S.L. and SEMNIM. All rights reserved.
dc.language.isoeng
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleFDG PET/CT in monitoring treatment of retroperitoneal fibrosis
dc.typeMakale
dc.relation.journalREVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume31
dc.identifier.issue6
dc.identifier.startpage338
dc.identifier.endpage339
dc.contributor.firstauthorID206780


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster